Release Date: 23/06/09 12:49 Summary: Appendix 3B Price Sensitive: No Download Document 69.73KB Download
TLX Telix gets its foot in the FDA door bringing prostate cancer detection closer to neglected Americans
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market